Related Experiment Video
Updated: Apr 29, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Mechanisms promoting escape from mitotic stress-induced tumor cell death
Rebecca Sinnott1, Leah Winters2, Brittany Larson3
1Authors' Affiliations: Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill;
Abstract:
Non-small cell lung cancer (NSCLC) is notorious for its paltry responses to first-line therapeutic regimens. In contrast to acquired chemoresistance, little is known about the molecular underpinnings of the intrinsic resistance of chemo-naïve NSCLC. Here we report that intrinsic resistance to paclitaxel in NSCLC occurs at a cell-autonomous level because of the uncoupling of mitotic defects from apoptosis. To identify components that permit escape from mitotic stress-induced death, we used a genome-wide RNAi-based strategy, which combines a high-throughput toxicity screen with a live-cell imaging platform to measure mitotic fate. This strategy revealed that prolonging mitotic arrest with a small molecule inhibitor of the APC/cyclosome could sensitize otherwise paclitaxel-resistant NSCLC. We also defined novel roles for CASC1 and TRIM69 in supporting resistance to spindle poisons. CASC1, which is frequently co-amplified with KRAS in lung tumors, is essential for microtubule polymerization and satisfaction of the spindle assembly checkpoint. TRIM69, which associates with spindle poles and promotes centrosomal clustering, is essential for formation of a bipolar spindle. Notably, RNAi-mediated attenuation of CASC1 or TRIM69 was sufficient to inhibit tumor growth in vivo. On the basis of our results, we hypothesize that tumor evolution selects for a permissive mitotic checkpoint, which may promote survival despite chromosome segregation errors. Attacking this adaptation may restore the apoptotic consequences of mitotic damage to permit the therapeutic eradication of drug-resistant cancer cells.
Insights
Intrinsic paclitaxel resistance in non-small cell lung cancer (NSCLC) stems from a failure to trigger apoptosis after mitotic defects. Targeting this resistance mechanism could enhance chemotherapy effectiveness for NSCLC patients.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Non-small cell lung cancer (NSCLC) exhibits poor responses to initial treatments.
- Intrinsic chemoresistance in NSCLC, unlike acquired resistance, is poorly understood.
- Paclitaxel resistance in NSCLC is linked to a cell-autonomous mechanism where mitotic defects do not induce apoptosis.
Purpose of the Study:
- To investigate the molecular basis of intrinsic paclitaxel resistance in NSCLC.
- To identify factors that enable cancer cells to evade apoptosis despite mitotic stress.
- To explore therapeutic strategies to overcome paclitaxel resistance in NSCLC.
Main Methods:
- Genome-wide RNAi screen combined with high-throughput toxicity and live-cell imaging.
- Utilized a small molecule inhibitor of the APC/cyclosome to prolong mitotic arrest.
- Investigated the roles of CASC1 and TRIM69 in resistance to spindle poisons.
Main Results:
- Prolonging mitotic arrest sensitized paclitaxel-resistant NSCLC cells.
- Identified CASC1 and TRIM69 as novel contributors to resistance against spindle poisons.
- CASC1 is crucial for microtubule polymerization and spindle assembly checkpoint function.
- TRIM69 is essential for bipolar spindle formation by associating with spindle poles and promoting centrosomal clustering.
- RNAi-mediated reduction of CASC1 or TRIM69 inhibited tumor growth in vivo.
Conclusions:
- Intrinsic paclitaxel resistance in NSCLC is mediated by a permissive mitotic checkpoint that allows survival despite chromosomal instability.
- CASC1 and TRIM69 play critical roles in this resistance mechanism.
- Targeting this adaptation by restoring apoptotic responses to mitotic damage offers a potential strategy for treating drug-resistant NSCLC.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells

